Grant Jerome Alan sold $3.9M of UTI

Grant Jerome Alan (Chief Executive Officer) sold 94,500 shares of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) at an average of $41.40 ($41.15–$41.63, $3.91M total) across 2 trades on 2026-06-29.

Original reporting
SEC EDGAR · Grant Jerome Alan
Published Jul 1, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 12:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UTI
Neutral
medium confidence
Mentioned
$UTI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UTINeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity or other disclosures, but this text alone does not introduce new operating or financial information.

02

Market read

A primary-source insider sale totaling ~$3.91M is disclosed, which can influence short-term sentiment but lacks fundamental catalysts.

03

What to watch

The filing states no pre-arranged 10b5-1 plan, which can increase scrutiny, but the article provides no stated reason for the sale or any accompanying operational news.

Relevance 6/10Novelty 5/10Timing: immediately after the 2026-06-29 insider sale; filed 2026-06-30 after market close

Background

The article is an SEC Form 4 insider transaction: CEO Grant Jerome Alan sold shares of Universal Technical Institute Inc.

Company-level read

Ticker impact

$UTINeutralMedium confidence
Context

SEC Form 4 shows CEO Grant Jerome Alan sold 94,500 shares of UTI for about $3.91M on 2026-06-29.

Expected impact

Likely limited near-term price impact; any effect is sentiment-driven and typically fades unless repeated or paired with other disclosures.

Evidence & confidence

The filing is primary-source and time-stamped, but it provides no new company performance, guidance, or deal information; also notes no 10b5-1 plan.

Market effects

No sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine liquidity events; the disclosed sale size may not imply bearish expectations without additional context.

Key entities

  • Universal Technical Institute Inc

    Issuer of the Form 4 insider sale by its CEO.

  • Grant Jerome Alan

    CEO and officer/director who sold 94,500 shares in two trades on 2026-06-29.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UTIHighAI 9/10

Universal Technical Institute falls on weak guidance

Universal Technical Institute (UTI) reported Q4 earnings of $0.32 per share, missing estimates of $0.52. Revenue rose 6.0% to $235.9M, slightly beating expectations. Fiscal 2027 guidance was below expectations, with EPS projected at $0.00 to $0.09. The company attributed the decline to strategic growth investments. Shares fell 10% in after-hours trading.

$UTIMed

Universal Technical Institute Reports Fiscal Year 2026 Fourth Quarter and Year-End Results

UNIVERSAL TECHNICAL INSTITUTE INC (UTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Universal Technical Institute Reports Fiscal Year 2026 Fourth Quarter and Year-End Results Company Unveils Next-Generation UTI Campus, Skilled Trades Max, and Details Plan for Up to 12 New Campuses and Approximately 45 New Programs for Fiscal 2027 Through Fiscal 2029

$UTILow

Why Universal Technical Institute Stock Zoomed 10% Higher Today

Universal Technical Institute (UTI) shares rose 10% on Monday without company-specific news. The increase followed Lincoln Educational Services' (LINC) Q3 report, showing 13% revenue growth and 24% net profit increase. LINC cited a U.S. skilled trades worker shortage as a key factor. UTI is set to report Q4 earnings on Nov. 18, with analysts expecting 5% revenue growth to $235M and 57% EPS increase to $0.36.